Christopher Wilcox, MD, PhD, FAH
Christopher S. Wilcox, M.D., Ph.D., is George E. Schreiner Professor of Medicine and Chief of the Division of Nephrology and Hypertension at the Georgetown University School of Medicine where he is co-director of the Angiogenesis Program, Vice chair for Research and Academic Affairs in the Department of Medicine and Founding Director of the Georgetown University Cardiovascular Kidney Hypertension Institute. A native of the United Kingdom, Dr. Wilcox attended Oxford University and the Middlesex Hospital Medical School in London which led to his medical degree from Oxford University in 1968. He remained at Middlesex Hospital Medical School and Affiliated Hospitals for residency training in internal medicine and fellowship training in nephrology and hypertension. He earned his Ph.D. degree in renal physiology from London University in 1974. He was a lecturer in Neurology, Physiology, and in Clinical Pharmacology of the Middlesex Hospital. From 1975-1980 Dr. Wilcox moved to St. Mary’s Hospital Medical School at the University of London where he was a professor of medicine and Deputy Director of the Medical Department. He spent one year at Yale an a visiting professor and subsequently was recruited to the Brigham and Women’s Hospital where he was Assistant Professor of Medicine and Clinical Pharmacology in the Harvard Medical School from 1980-1984. He was recruited to the University of Florida, College of Medicine where he served as Professor of Medicine and of Pharmacology and Therapeutics from 1984-1994. He was Director of the Hypertension Center at the University of Florida and chief of Nephrology of the VA Medical Centre. In 1994 Dr. Wilcox was recruited to his present positions as George E. Schreiner Professor of Nephrology and Chief of the Division of Nephrology and Hypertension at the Georgetown University and Founder and Director of the Georgetown University Cardiovascular Kidney Hypertension Institute. He has served on the editorial boards of the American Journal of Physiology (Regulatory, Integrative, and Comparative Physiology; and Renal Physiology), the Journal of the American Society of Nephrology, Kidney International, Nature Clinical Practice-Nephrology, Clinical Science, Hypertension, the Journal of the Renin Angiotensin Aldosterone System, and the American Journal of Hypertension. He has served on several NIH study sections and currently chairs the Renal Disease Study Section.Dr. Wilcox has received many honors including election to membership in the American Society of Clinical Investigation and the Association of American Physicians; selection as the Louis K. Dahl Lecturer of the American Heart Association, the Ernest H. Starling Lecturer of the American Physiological Society, the Robert W. Berliner lecturer at Yale University, and a MERIT Award from the National Institutes of Health. He received the Lifetime Achievement Award from the American Heart Association Council on High Blood Pressure Research. He is a Fellow of the Royal Society of Medicine, a Fellow of the Royal College of Physicians of the UK, and Master of the American College of Physicians.
Dr. Wilcox’s work is supported by two individual investigators’ awards from the NIH in the fields of nitric oxide and prostaglandins. He is also principle investigator of an NIH program project grant on oxidative stress and an NIH fellowship training grant. Dr. Wilcox’s grants from the NIH total $17 Million. He also directs clinical research projects. He is an active clinician specializing in hypertension and is medical director of a dialysis unit.